Team Science Efforts in Type 1 Diabetes Research
This lecture will provide examples of team science projects in the field of Type 1 diabetes, describe the goals and progress, and how these projects operate and apply the science of team science, while facing challenges and opportunities. This is the final seminar in this series dealing with Team Science in Translational Research.
Alberto Pugliese, M.D.
Dr. Alberto Pugliese is an investigator in the research area of type 1 diabetes. After training with George Eisenbarth, M.D., Ph.D., at the Joslin Diabetes Center and the Barbara Davis Center for Childhood Diabetes, he moved to the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine, where he is currently a Professor of Medicine, Microbiology and Immunology. He is the Head of the Immunogenetics Program at the DRI. During the past 20 years he has been involved in clinical and basic research about the immunology, genetics, prediction and prevention of type 1 diabetes (T1D).
About Miami CTSI
Created in 2012, the Miami Clinical and Translational Science Institute () drives research translation into evidence-based clinical and community practices that improve the health of South Florida’s diverse population.
In a community comprised of 85 percent racial and ethnic minorities, the Miami makes significant contributions in minority health and health disparities and in training underrepresented minorities in clinical, translational, and community-engaged research.
The Miami educates, connects, and supports research teams by building the distinct science of clinical translational research, fostering collaboration, and managing the resources needed to sustain success in these areas.
Made up of the University of Miami, Jackson Memorial Health System, and Miami VA Healthcare System, we are jointly funded by the National Center for Advancing Translational Sciences and the National Institute on Minority Health and Health Disparities. The Miami is member of the National Clinical and Translational Science Award () Consortium, a prestigious group of 60 world-class academic research institutions that is transforming the way biomedical research is conducted across the country.
The CTSA’s goal is to increase the efficiency and speed of moving scientific discoveries into treatments and interventions for better health.
Join millions of people on Eventbrite.